Intravenous Cangrelor Versus Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Endovascular Thrombectomy for Middle Cerebral Artery Stroke: A Multi-Institutional Propensity Score-Matched Analysis. (PubMed, AJNR Am J Neuroradiol) - Jul 31, 2026 - "Both drugs demonstrated comparable outcomes overall. In an exploratory angioplasty/stenting subgroup, cangrelor was associated with reduced hemorrhagic complications but increased recurrent stroke, suggesting a complex risk-benefit tradeoff requiring individualized antiplatelet selection."
Journal • Cardiovascular • Cerebral Hemorrhage • CNS Disorders • Hematological Disorders
|
|
Adam A Dmytriw; Ahmed Y Azzam; Ajay Malhotra; Anthony P Terraciano; Bluyé DeMessie; Brian Connolly; Daniel Mandel; David J Altschul; Dhairya A Lakhani; Dheeraj Gandhi; Hamza A Salim; Hasan Jamil; Huanwen Chen; Jay Kakadiya; Majid Khan; Marc Buzzeli; Marco Colasurdo; Matthew K McIntyre; Mohamad Ezzeldin; Muhammed Amir Essibayi; Neil Haranhalli; Pranjal Rai; Sami Al Kasab; Vivek S Yedavalli
|